{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"description":"To assess the incidence of Epstein-Barr virus (EBV)-associated lymphoproliferative disorder or EBV reactivation requiring therapy post DLI.","groups":[{"description":"Patients who did not move forward to DLI","id":"OG000","title":"Transplant Only"},{"description":"Proceeded to DLI per protocol","id":"OG001","title":"Transplat Plus DLI"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"all patients who received DLI","reportingStatus":"POSTED","timeFrame":"1 year","title":"To Assess the Incidence of Epstein-Barr Virus -PTLD or EBV Reactivation Requiring Therapy Post DLI.","type":"SECONDARY","unitOfMeasure":"Participants"}